Caeruleus Genomics
Adam Cribbs is the Co-Founder and CTO at Caeruleus Genomics, specializing in Precision Medicine. Previously, Adam has held various positions at the University of Oxford, including Associate Professor, Group Leader in Systems Biology, and MRC Career Development Fellow in Computational Genomics. Before that, Adam was a Postdoctoral Researcher at Imperial College London, where Adam conducted doctoral studies in epigenetics in autoimmunity. Adam is skilled in a variety of program languages and techniques within the genomics and molecular biology fields.
This person is not in any teams
Caeruleus Genomics
Caeruleus Genomics has developed a proprietary discovery platform to profile disease multimodally and with unprecedented accuracy. To do this, we overcame the core bottlenecks to industrialising single-cell long-read sequencing. We use our in-house computational and sequencing platform to profile human tissues functionally, uncover new RNA targets and develop more effective therapies in oncology and rare diseases. Spun out from Oxford University by experts in functional genomics, therapeutic target discovery and computational biology.